Abstract

Simulating the Transmission and Recovery from Ebola Virus Disease (EVD) to Understand the Impact of Experimental Drug Might Have in Three West African Countries

Ebola Virus Disease (EVD) has become one of the deadly epidemics that have caused the death of many in recent times. Three West African countries; Liberia, Sierra Leone and Guinea have experienced the worst spread of the disease since the disease outbreak recently. There have been suspected, probable and confirmed 17,145 reported cases of the disease in all the affected countries, with 6,070 reported deaths. This paper employs the SIRS (Susceptible, Infected, Recovered and Susceptible) model and cellular automata model (global stochastic contact model) with real parameters that include average contact, recovery period, infectious period and transmission probability to simulate in order to understand how the new Ebola experimental drug (ZMAPP) that is used to cure 3 patients could impact on a population hit by the disease and the period of time it will take to eradicate the epidemic. The study can serve as a basis for understanding the vaccination effect on Ebola virus based on real parameters.


Author(s):

Mohd Khanapi Abd Ghani



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • Healthcare IT
    August 21-22, 2018 Paris, France
  • Healthcare and Hospital Management
    September 19-20, 2018 Vancouver, British Columbia, Canada
  • Medical Sociology & Public Health
    September 21-22, 2018 Dallas, Texas, USA
Flyer image

Abstracted/Indexed in

  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research